# FDA Approves Lilly's Foundayo, First GLP-1 Weight Loss Pill With No Food or Water Restrictions

*2026-04-04 20:04 UTC · Science · 1 min read*

> FDA approves Lilly's Foundayo, a once-daily GLP-1 weight loss pill with no food or water restrictions, priced from $25/month.

The FDA approved Eli Lilly's Foundayo (orforglipron) on April 1, making it the first oral GLP-1 weight loss drug that can be taken any time of day without food or water restrictions. The approval came just 50 days after filing — the fastest new molecular entity approval since 2002 — under the National Priority Voucher program.

In clinical trials, patients on the highest dose lost an average of 12% body weight over 72 weeks, compared to 0.9% for placebo. Lilly is pricing Foundayo at $25/month with commercial insurance, $149/month for self-pay, and $50/month for eligible Medicare Part D patients starting July 2026. Prescriptions open immediately via LillyDirect with shipping beginning April 6.

The approval intensifies competition in the booming GLP-1 market, where injectable drugs like Wegovy and Zepbound have dominated. Unlike the recently approved Wegovy pill, Foundayo has no restrictions on when it can be taken or what patients eat or drink beforehand, giving it a significant convenience advantage in the rapidly expanding weight loss drug landscape.

## Sources

- [investor.lilly.com](https://investor.lilly.com/news-releases/news-release-details/fda-approves-lillys-foundayotm-orforglipron-only-glp-1-pill)
- [cnbc.com](https://www.cnbc.com/2026/04/01/eli-lilly-glp-1-pill-foundayo-approved-for-obesity.html)
- [cnn.com](https://www.cnn.com/2026/04/01/health/foundayo-weight-loss-pill-fda-approval)

---
TechTools News · https://techtools.cz/tools/news/article/1273-fda-approves-lilly-s-foundayo-first-glp-1-weight-loss-pill-with-no-food-or
Česká verze: https://techtools.cz/tools/news/clanek/1325-fda-schvalila-lek-foundayo-od-lilly-prvni-glp-1-pilulku-na-hubnuti-bez-omezeni
